Sardalla, Efren G.

HRN: 29-39-15  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2026
CEFTAZIDIME 1GM (VIAL)
07/29/2026
08/05/2026
IV
2g
Q8
CAPMR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: